ethyl 7-oxo-7-(3-trifluoromethylphenyl)heptanoate, 97.0%, 2g

1,4-butanediol, min. 99.0%, for synthesis, 10 l, plastic packaging.

5-Bromo-2-isopropylpyridine, 97%, 250mg

{2-methanesulfonyl-1-[3-(morpholin-4-yl)propyl]-1H-imidazol-5-yl}methanol, 95.0%, 2g

(S)-2-Aminonon-8-enoic acid, 95.0%, 1g

2,6-Dibromo-4-methoxyaniline, 95.0%, 1g

1,3-Dimesityl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 95%, 10g

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 250mg

Autoclavable containers with rectangular lid, 114 l, 1 piece

1-Phenylazetidin-3-ol, 95.0%, 250mg

1-(2-Cyanophenyl)piperidine-3-carboxylic acid, 5g

ethyl 2-anilino-4-oxo-4,5-dihydrothiophene-3-carboxylate, 95+%, 1g

1-(2-Chlorothiazol-5-yl)ethan-1-amine hydrochloride, 98%, 250mg